海南海药与爱康集团达成战略合作 布局大健康领域

Core Viewpoint - Hainan Haiyao has signed a strategic cooperation framework agreement with Aikang International Group to enhance collaboration in the health sector and promote the construction of Hainan Free Trade Port, aiming to expand market presence in both China and Malaysia [1][2]. Group 1: Strategic Cooperation - Hainan Haiyao will act as the exclusive agent for Aikang Group's health products in mainland China, responsible for promotion, sales, and after-sales service [1]. - Aikang Group will serve as the exclusive agent for Hainan Haiyao's traditional Chinese medicine products in Malaysia, facilitating their entry into the Malaysian market [1][2]. - Both parties will conduct market research and develop promotional strategies tailored to Malaysian consumer needs, enhancing brand recognition in Southeast Asia [1][2]. Group 2: Operational Framework - Annual cooperation summits will be held alternately in Hainan Free Trade Port and Malaysia to assess progress and plan future actions [2]. - A joint working group will be established to oversee the implementation of the cooperation, ensuring effective communication and problem resolution [2]. - The agreement lays a foundation for future formal cooperation, leveraging shared resources and expertise to enhance product offerings in the health sector [2]. Group 3: Company Background - Hainan Haiyao, established in 1965 and listed in 1994, is a leading pharmaceutical enterprise in Hainan Province, with a diverse product range including intermediates, active pharmaceutical ingredients, innovative chemical drugs, modern Chinese medicine, biological drugs, and high-end medical devices [3].